nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
|
Ben Khaled, Najib |
|
|
6 |
6 |
p. |
artikel |
2 |
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial
|
Hoegen-Saßmannshausen, Philipp |
|
|
6 |
6 |
p. |
artikel |
3 |
Contents
|
|
|
|
6 |
6 |
p. |
artikel |
4 |
Copyright and information
|
|
|
|
6 |
6 |
p. |
artikel |
5 |
Corrigendum to: “Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results” [JHEP Reports 5 (2019) 101041]
|
van Baar, Annieke C.G. |
|
|
6 |
6 |
p. |
artikel |
6 |
Corrigendum to “O-GlcNAc transferase acts as a critical nutritional node for the control of liver homeostasis” [JHEP Reports 6 [2024] 100878]
|
Ortega-Prieto, Paula |
|
|
6 |
6 |
p. |
artikel |
7 |
Corrigendum to ‘Predicting post-resection recurrence by integrating imaging-based surrogates of distinct vascular patterns of hepatocellular carcinoma’ (JHEP Reports 5 [2023] 100806)
|
Meng, Xiang-Pan |
|
|
6 |
6 |
p. |
artikel |
8 |
Corrigendum to ‘Transplant oncology – Current indications and strategies to advance the field’ [JHEP Reports 6 (2024) 100965]
|
Krendl, Felix J. |
|
|
6 |
6 |
p. |
artikel |
9 |
CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis
|
Niehaus, Christian |
|
|
6 |
6 |
p. |
artikel |
10 |
Editorial Board page
|
|
|
|
6 |
6 |
p. |
artikel |
11 |
Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality
|
Pearson, Madeline |
|
|
6 |
6 |
p. |
artikel |
12 |
Erratum Regarding Previously Published Articles
|
|
|
|
6 |
6 |
p. |
artikel |
13 |
Erratum Regarding Previously Published Articles
|
|
|
|
6 |
6 |
p. |
artikel |
14 |
Erratum to ‘B4GALNT1 promotes hepatocellular carcinoma stemness and progression via integrin α2β1-mediated FAK and AKT activation’ (JHEP Reports 5 [2023] 100903)
|
Tang, Yao |
|
|
6 |
6 |
p. |
artikel |
15 |
Erratum to “Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis” [JHEP Reports 6 (2024) 100949]
|
McKiernan, Patrick |
|
|
6 |
6 |
p. |
artikel |
16 |
Glycogen synthase kinase 3 activity enhances liver inflammation in MASH
|
Khoury, Mireille |
|
|
6 |
6 |
p. |
artikel |
17 |
Investigating shared genetic architecture between inflammatory bowel diseases and primary biliary cholangitis
|
Huang, Wentao |
|
|
6 |
6 |
p. |
artikel |
18 |
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinoma
|
Jackson, Linsey E. |
|
|
6 |
6 |
p. |
artikel |
19 |
Oxytocin alleviates liver fibrosis via hepatic macrophages
|
Zhai, Xiangyu |
|
|
6 |
6 |
p. |
artikel |
20 |
Paediatric hepatocellular adenomas: Lessons from a systematic review of relevant literature
|
Scheers, Isabelle |
|
|
6 |
6 |
p. |
artikel |
21 |
Predictive role of hepatic venous pressure gradient in bleeding events among patients with cirrhosis undergoing orthotopic liver transplantation
|
Giabicani, Mikhael |
|
|
6 |
6 |
p. |
artikel |
22 |
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma
|
Kendall, Timothy |
|
|
6 |
6 |
p. |
artikel |